A. Bosio

297P The genetic profile of primary and recurrent gliomas: A mono-institutional experience using next-generation sequencing

V. Zagonel, G. Lombardi, M. Maccari, 2022, Annals of Oncology.

P02.02.A Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: a large mono institutional experience

M. Fassan, V. Zagonel, G. Lombardi, 2022, Neuro-Oncology.

Recurrent Glioblastoma: What Is the Route?

G. Lombardi, A. Bosio, 2023, Cancers.

Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.

V. Zagonel, G. Lombardi, M. Caccese, 2023, European journal of cancer.

Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities

M. Caccese, G. Cerretti, M. Maccari, 2023, The oncologist.